2023
Variation in hospital use of cardiac resynchronization therapy-defibrillator among eligible patients and association with clinical outcomes
Chui P, Lan Z, Freeman J, Enriquez A, Khera R, Akar J, Masoudi F, Ong E, Curtis J. Variation in hospital use of cardiac resynchronization therapy-defibrillator among eligible patients and association with clinical outcomes. Heart Rhythm 2023, 20: 1000-1008. PMID: 36963741, DOI: 10.1016/j.hrthm.2023.03.022.Peer-Reviewed Original ResearchMeSH KeywordsAgedCardiac Resynchronization TherapyDefibrillators, ImplantableHeart FailureHospitalsHumansMedicareTreatment OutcomeUnited StatesConceptsEligible patientsICD RegistryCardiac resynchronizationNational Cardiovascular Data Registry ICD RegistryCRT-D implantationCRT-D useHospital-level outcomesStrong guideline recommendationsHospital-level variationPatient-level outcomesIntraclass correlation coefficientQuality improvement effortsHospital mortalityGuideline indicationsReadmission ratesSelect patientsClinical outcomesGuideline recommendationsHospital variationHospital ratesUse of CRTHospital levelHospital usePatientsCase mix
2014
Management of Hypertrophic Cardiomyopathy
Enriquez AD, Goldman ME. Management of Hypertrophic Cardiomyopathy. Annals Of Global Health 2014, 80: 35-45. PMID: 24751563, DOI: 10.1016/j.aogh.2013.12.004.Peer-Reviewed Original ResearchMeSH KeywordsAtrial FibrillationCardiomyopathy, Hypertrophic, FamilialDeath, Sudden, CardiacDefibrillators, ImplantableHeart FailureHumansRisk FactorsVentricular Outflow ObstructionConceptsSudden cardiac deathHypertrophic cardiomyopathyHeart failureAtrial fibrillationHCM patientsManagement of HCMCommon genetic cardiovascular diseaseUnexplained myocardial hypertrophyAlcohol septal ablationOutflow tract obstructionRhythm control strategyPathophysiology of HCMRisk of thromboembolismMajority of patientsGeneral adult populationGenetic cardiovascular diseaseAutosomal dominant diseaseFamily membersSurgical myectomyRefractory symptomsRestrictive physiologySeptal ablationTract obstructionYounger patientsCardiac death
2013
The Role of Implantable Cardioverter-Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices
Enriquez AD, Calenda B, Miller MA, Anyanwu AC, Pinney SP. The Role of Implantable Cardioverter-Defibrillators in Patients With Continuous Flow Left Ventricular Assist Devices. Circulation Arrhythmia And Electrophysiology 2013, 6: 668-674. PMID: 23873139, DOI: 10.1161/circep.113.000457.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedArrhythmias, CardiacChi-Square DistributionDefibrillators, ImplantableElectric CountershockFemaleHeart FailureHeart TransplantationHeart-Assist DevicesHumansKaplan-Meier EstimateLogistic ModelsMaleMiddle AgedMultivariate AnalysisNew York CityProportional Hazards ModelsProsthesis DesignRetrospective StudiesRisk FactorsTime FactorsTreatment OutcomeVentricular Function, LeftWaiting ListsYoung AdultConceptsVentricular arrhythmiasActive ICDPost-LVAD ventricular arrhythmiasVentricular assist device supportAssist device supportContinuous-flow LVADHeartMate II LVADEnd of studyImplantable cardioverter defibrillatorVentricular assist deviceAppropriate shocksConsecutive patientsImproved survivalIschemic cardiomyopathySingle centerWorse prognosisMedian lengthMean agePatient populationCardioverter defibrillatorPatientsDevice supportAssist deviceICDLVAD